Surface Transforms plc (LON:SCE) Chairman David Bundred caught up with DirectorsTalk for an exclusive interview to discuss the two new contracts, the settlement of a £300,000 claim, announcement of mainstream..
Redx Pharma plc (LON: REDX) is a clinical-stage R&D company focused on drugs targeting oncology and fibrotic disease. 2018 was a year that reset the benchmarks – new management team,..
Pantheon International Plc (LON: PIN) has today provided a performance update for the 31 May 2019. Highlights 2,770.6p NAV per share +6.5% NAV per share growth for the month £1.5bn..
Greencoat UK Wind PLC (LON:UKW), the leading listed infrastructure fund, invested in operating UK wind farms, today advised that it will announce its Net Asset Value as of 30 June..
Workspace Group plc (LON: WKP) have today provided a first quarter business update. HIGHLIGHTS · Good level of customer demand in the first quarter with enquiries averaging 1,060 per month..
Diploma PLC (LON:DPLM), the international group supplying specialised technical products, technical services and value-add services, has today announced the acquisition of the assets and trade of Virginia Sealing Products, Inc...
Reckitt Benckiser plc (LON: RB.) today announced that it has reached agreements with the U.S. Department of Justice and the Federal Trade Commission to resolve the long-running investigation into the..
Land Securities Group PLC (LON: LAND) announced today that Robert Noel, Chief Executive, has informed the Board of his intention to retire from Landsec during 2020. The Board will commence..
Jubilee Metals Group plc (LON: JLP), the AIM and AltX traded metals processing company, has today provided an update on its various projects in South Africa and Zambia, including confirmation..
Marshall Motor Holdings plc (LON: MMH), one of the UK’s leading automotive retail groups, issued today its pre-close trading statement ahead of the release on 13 August 2019 of its..
Ilika plc (LON: IKA) a pioneer in solid-state battery technology, announced today its full-year results for the year ended 30 April 2019. Operational highlights: · Implementation of Stereax® development programmes..
Allergy Therapeutics plc (LON: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has today provided a trading update for the year ended 30 June 2019 ahead of..
